Riskpilot← Back to searchSign inGet full accessClarudden AB
ABActiveOrg 5567261036Billo Ptr 043 -N Birger Jarlsg 37bMedical specialists activities · NACE 8622Est. 20070 employees
Revenue 2025
SEK 817K
EBITDA margin
31.7%
+16553% vs 2024
Equity ratio
90.1%
Financial strength
Net profit 2025
SEK 206K
+21698% vs 2024
| Revenue | SEK 817K | — |
| EBITDA | SEK 259K | +16553% |
| Net profit | SEK 206K | +21698% |
| Total assets | SEK 535K | +89% |
| Equity | SEK 482K | +75% |
| Employees | 0 | — |
Legal name
Clarudden AB
Org number
5567261036
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 mars 2007
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom medicinsk radiologi, samt därutöver äga och förvalta fastigheter, bolag, värdepapper, och därmed förenlig verksamhet.
Address
Billo Ptr 043 -N Birger Jarlsg 37b
Phone
+46708232426
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 306 | 644 | 717 | 0 | 817 |
| Staff expenses | — | — | −24 | −0 | — |
| EBITDA | 277 | 619 | 624 | −2 | 259 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 277 | 619 | 624 | −2 | 259 |
| Net financials | — | 1 | 14 | 1 | — |
| Profit before tax | 277 | 620 | 638 | −1 | 259 |
| Tax | −0 | — | −28 | — | −53 |
| Net profit | 277 | 620 | 610 | −1 | 206 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 485 | 865 | 956 | 283 | 535 |
| Equity | 479 | 858 | 918 | 276 | 482 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 6 | 6 | 38 | 7 | 53 |
| Total debt | 6 | 6 | 38 | 7 | 53 |
EBITDA margin
31.7%
This company
15.8%
Market median
+101% vs market
20212025
Equity ratio
90.1%
This company
38.2%
Market median
+136% vs market
20212025
Return on equity
42.7%
This company
18.4%
Market median
+132% vs market
20212025
Net profit margin
25.2%
This company
8.1%
Market median
+211% vs market
20212025
Asset turnover
1.53×
This company
1.12×
Market median
+37% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JJ Authorized Recipient of Service | Authorized Recipient of Service | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Clarudden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Julia Johanna Hagman Bäckman | Authorized Recipient of Service | 0 companies |
| Mikael Aron Langnas | Board of Directors | 0 companies |
| Lisa Karin Friling | Deputy Board Member | 0 companies |
| Stina Linnea Friling | Board of Directors | 0 companies |